The stock of BioCardia Inc (BCDA) has gone up by 38.52% for the week, with a -9.70% drop in the past month and a 6.61% rise in the past quarter. The volatility ratio for the week is 8.67%, and the volatility levels for the past 30 days are 9.71% for BCDA. The simple moving average for the past 20 days is 19.83% for BCDA’s stock, with a -2.44% simple moving average for the past 200 days.
Is It Worth Investing in BioCardia Inc (NASDAQ: BCDA) Right Now?
Moreover, the 36-month beta value for BCDA is 0.99. Analysts have varying opinions on the stock, with 1 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for BCDA is 3.69M and currently, short sellers hold a 1.08% of that float. On April 29, 2025, BCDA’s average trading volume was 66.47K shares.
BCDA) stock’s latest price update
The stock of BioCardia Inc (NASDAQ: BCDA) has increased by 22.84 when compared to last closing price of 1.97.Despite this, the company has seen a gain of 38.52% in its stock price over the last five trading days. globenewswire.com reported 2025-04-11 that CardiAMP HF II is Evaluating the CardiAMP™ Cell Therapy Product for Treating Patients with Ischemic Heart Failure of Reduced Ejection Fraction and Elevated Markers of Cardiac Stress
BCDA Trading at 4.82% from the 50-Day Moving Average
After a stumble in the market that brought BCDA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -60.65% of loss for the given period.
Volatility was left at 9.71%, however, over the last 30 days, the volatility rate increased by 8.67%, as shares sank -13.57% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -11.03% lower at present.
During the last 5 trading sessions, BCDA rose by +38.52%, which changed the moving average for the period of 200-days by -20.13% in comparison to the 20-day moving average, which settled at $2.0200. In addition, BioCardia Inc saw 11.01% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at BCDA starting from KRASNO RICHARD M, who purchase 13,123 shares at the price of $1.91 back on Apr 23 ’25. After this action, KRASNO RICHARD M now owns 16,268 shares of BioCardia Inc, valued at $24,999 using the latest closing price.
McClung David, the Chief Financial Officer of BioCardia Inc, purchase 13,123 shares at $1.91 during a trade that took place back on Apr 23 ’25, which means that McClung David is holding 43,131 shares at $24,999 based on the most recent closing price.
Stock Fundamentals for BCDA
Current profitability levels for the company are sitting at:
- -137.95 for the present operating margin
- -2.66 for the gross margin
The net margin for BioCardia Inc stands at -137.0. The total capital return value is set at -5.7. Equity return is now at value -737.89, with -236.81 for asset returns.
Based on BioCardia Inc (BCDA), the company’s capital structure generated 0.53 points at debt to capital in total, while cash flow to debt ratio is standing at -8.44.
Currently, EBITDA for the company is -7.93 million with net debt to EBITDA at 0.18. When we switch over and look at the enterprise to sales, we see a ratio of 170.79. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.13.
Conclusion
To wrap up, the performance of BioCardia Inc (BCDA) has been mixed in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
